The global viral vector production (research-use) market is entering a critical infrastructure expansion phase, driven by the rapid maturation of gene and cell therapy pipelines. As biopharmaceutical innovation shifts toward genetic medicines and advanced biologics, demand for high-quality research-grade viral vectors is rising sharply—positioning this market as a foundational...